In Face of Thermo-Fisher Pact, Qiagen to Stick To M&A Plan; Won t Sacrifice Speed for Size | GenomeWeb

Following his company's $38-million acquisition last week of Gentra Systems, Qiagen CEO Peer Schatz suggested that the company was likely to stick with its strategy of acquiring smaller companies that generate near-term value.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.